Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.58
+0.43 (1.71%)
At close: Jan 14, 2026, 4:00 PM EST
25.49
-0.09 (-0.35%)
Pre-market: Jan 15, 2026, 8:44 AM EST
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
$775,123
Profits / Employee
$121,346
Market Cap
145.44B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
| Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
| Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
| Dec 31, 2021 | 79,000 | 500 | 0.64% |
| Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
| Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
| Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
| Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
| Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
| Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
| Dec 31, 2014 | 78,300 | 600 | 0.77% |
| Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
| Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
| Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
| Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
| Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
| Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
| Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
| Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
| Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
| Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
| Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
| Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
| Dec 31, 2001 | 90,000 | 0 | - |
| Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
| Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
| Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
| Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
| Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
| Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
| Dec 31, 1994 | 40,800 | 300 | 0.74% |
| Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PFE News
- 2 days ago - Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy - Seeking Alpha
- 2 days ago - Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra - Reuters
- 2 days ago - Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer - Business Wire
- 5 days ago - Healthy Returns: What to expect from pharma at the JPM conference - CNBC
- 7 days ago - Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity - Business Wire
- 7 days ago - Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio - Business Wire
- 8 days ago - Quant Q&A With Steven Cress - Seeking Alpha